Services

HERON collaborates with clients across all segments of healthcare from clinical and commercial development to population-based health management, to research, policy, and advocacy. Healthcare companies can be assured that when they engage HERON, we will deliver a best practices blend of scientific and analytic rigor and insight informed by over a decade of experience in a continuously shifting global marketplace.

HERON’s Evidence-to-Outcomes Service Portfolio^™ includes:  

Evidence Review 

Informing needs assessment, value definition, and reimbursement and market access stratgeies, HERON’s systematic and literature reviews are based on benchmark protocols and meta-analyses conducted by globally regarded scientists and statisticians and supported by HERON’s proprietary database. 

Economic Evaluation

HERON’s expert team of health economists and modelers develop creative, regulatory compliant, and reimbursement-focused tools that identify and express the economic value of products to those who pay for and deliver health care. With the target audience always in mind, HERON models are clear and transparent in the most compelling manner, interpreting complex health economic models for dissemination into wider pricing, health outcomes, and reimbursement support programs. 

Pricing & Market Access

Translating benchmark evidence and insight to shape payer/stakeholder perception and achieve optimal reimbursement positioning, HERON’s Pricing & Market Access practice supports clients as they navigate global market challenges and opportunities. With healthcare reform front and center on every continent and within every related governmental body, HERON’s exposure to and experience in Health Technology Assessment (HTA) and non-HTA markets assures that strategy and science are aligned to generate the most positive outcomes.